• <em>C634Y</em> mutation in <em>RET</em>-induced multiple endocrine neoplasia type 2A: A case report
• <em>MAX</em> germline mutation-associated pheochromocytoma-paraganglioma syndrome: multiple endocrine neoplasia type 5
• 18F-FDG PET/CT Unveils Coexistent Myelomatous Hepatosplenic and Thyroid Cartilage Involvement: A Rare Presentation in Multiple Myeloma
• 30 years of prophylactic thyroidectomy for hereditary medullary thyroid cancer : A milestone in translational medicine
• A case report of multiple endocrine neoplasia type 2B
• A comparison of the histopathologic features of thyroid carcinomas with NTRK fusions to those with other malignant fusions
• A practical nomogram for preoperatively predicting lateral cervical lymph node metastasis in medullary thyroid carcinoma: a dual-center retrospective study
• Accuracy and diagnostic performance of the Bethesda system for reporting thyroid cytopathology in a tertiary endocrine surgical referral center in Belgium
• Anatomic Patterns of Nodal Spread in Unilateral Papillary and Medullary Thyroid Cancer
• Anatomical Patterns of Nodal Spread in Unilateral Papillary and Medullary Thyroid Cancer
• Beyond the Recommendations of the Clinical Guidelines for Medullary Thyroid Cancer - A Case Report
• Biodistribution and Radiation Dosimetry for 68Ga-DOTA-CCK-66, a Novel CCK2R-Targeting Compound for Imaging of Medullary Thyroid Cancer
• Biomarker identification of medullary thyroid carcinoma from gene expression profiles considering without-treatment and with-treatment studies-A bioinformatics approach
• Calcitonin-producing Duodenal Neuroendocrine Tumor: A Case Report and Literature Review
• Can Calcitonin Levels Guide Prophylactic Neck Dissection in Sporadic Medullary Thyroid Carcinoma?
• Changes in the diagnosis of thyroid tumours in the 5th edition of the WHO classification of endocrine neoplasms
• Changes of biochemical factors and the effect on recurrence of medullary thyroid carcinoma after surgery
• Cheminformatics-based identification of phosphorylated RET tyrosine kinase inhibitors for human cancer
• Clinical, Histopathological, and Radiological Profile of Patients Presenting With Thyroid Malignancies Among the Kerala Population
• Clues for Early Diagnosis of MEN2B Syndrome Before Medullary Thyroid Carcinoma
• Critically evaluated key points on hereditary medullary thyroid carcinoma
• Direct-Acting Oral Anticoagulants and Antiseizure Medications for Atrial Fibrillation and Epilepsy and Risk of Thromboembolic Events
• Does the extent of neck surgery based on preoperative calcitonin level influence survival in medullary thyroid carcinoma: a retrospective tertiary centre experience
• Durability of Response With Selpercatinib in Patients With RET-Activated Thyroid Cancer: Long-Term Safety and Efficacy From LIBRETTO-001
• Efficacy and safety of multikinase inhibitors for patients with refractory thyroid cancer: Systematic review and network meta-analysis
• Efficacy and safety of selpercatinib in treating RET-altered MTC: A single-arm meta-analysis
• Elevated Procalcitonin Levels can Occur in Bacterial Infections and also in Medullary Thyroid Carcinoma
• Experimental Study of Interference in Calcitonin Testing: A Case Report and Literature Review
• Expression of integrin alpha(v)beta(3) in medullary thyroid carcinoma
• False-Negative 68Ga-FAPI PET/CT in Pediatric Thyroid Medullary Carcinoma Seen With 68Ga-DOTATOC PET/CT and 18F-FDG PET/CT
• Fluctuating obliterative bronchiolitis in RET-mutant medullary thyroid cancer patient treated with selpercatinib
• From Diabetes to Oncology: Glucagon-like Peptide-1 (GLP-1) Receptor Agonist's Dual Role in Prostate Cancer
• Fulminant hypercorticism due to ACTG producing pheochromocytoma
• Fundamentals and Recent Advances in the Evaluation and Management of Medullary Thyroid Carcinoma
• Ganglioneuromatous polyposis associated with type 2 B multiple endocrine neoplasia (MEN 2B) - case report
• Genomic and Transcriptomic Landscape of RET Wild-Type Medullary Thyroid Cancer and Potential Use of Mitogen-Activated Protein Kinase-Targeted Therapy
• Glucagon-like peptide 1 receptor agonist use and risk of thyroid cancer: Scandinavian cohort study
• High prevalence of hypercalcitoninemia in a large cohort of adult and paediatric patients with PTH resistance syndromes
• High success rate of first proficiency testing for RET fusions and RET mutations in lung and thyroid cancer samples by various methods
• Immunotherapy for patients with thyroid cancer: a comprehensive appraisal
• Improved survival after primary tumor resection in distant metastasis medullary thyroid carcinoma: a population-based cohort study with propensity score matching
• In Vitro Effects of Boric Acid on Cell Cycle, Apoptosis, and miRNAs in Medullary Thyroid Cancer Cells
• INSM1 expression in neuroendocrine tumors in a tertiary care hospital
• Intra thyroid thymic carcinoma: A case report and literature review
• LINC00887 Acts as an Enhancer RNA to Promote Medullary Thyroid Carcinoma Progression by Binding with FOXQ1
• LncRNA ZFAS1 promotes invasion of medullary thyroid carcinoma by enhancing EPAS1 expression via miR-214-3p/UCHL1 axis
• Long-term survival outcomes of systemic therapy in patients with isolated and mixed medullary thyroid cancer
• Management of Advanced Medullary Thyroid Carcinoma: Current Systemic Therapy Options
• Medullary Thyroid Cancer: Epidemiology and Characteristics According to Data From the Marne-Ardennes Register 1975-2018
• Medullary Thyroid Cancer: Molecular Drivers and Immune Cellular Milieu of the Tumour Microenvironment-Implications for Systemic Treatment
• Medullary Thyroid Carcinoma in Patients with Graves' Disease-A Case Series and Literature Review
• Medullary Thyroid Carcinoma: A Unique Case Report
• MicroRNAs in thyroid cancer with focus on medullary thyroid carcinoma: potential therapeutic targets and diagnostic/prognostic markers and web based tools
• Minor role of TP53 and TERT promoter mutations in medullary thyroid carcinoma: report of new cases and revision of the literature
• Molecular imaging of thyroid and parathyroid diseases
• Molecular Pathology of Thyroid Tumors: Essential Points to Comprehend Regarding the Latest WHO Classification
• Multifocal Extramedullary Plasmacytoma of the Thyroid With Cervical and Paratracheal Lymph Node Involvement and Progression to Multiple Myeloma
• Multiple Endocrine Neoplasia Type 1, Type 2A, and Type 2B
• Neoadjuvant Treatment of Locally Advanced Thyroid Cancer: A Preliminary Latin American Experience
• New strategy for intraoperative phonosurgical management of recurrent laryngeal nerve infiltrated by thyroid carcinoma
• Next-Generation Sequencing in Sporadic Medullary Thyroid Cancer Patients: Mutation Profile and Disease Aggressiveness
• Not Only RET but NF1 and Chromosomal Instability Are Seen in Young Patients with Sporadic Medullary Thyroid Carcinoma
• Novel truncating germline variant reinforces TINF2 as a susceptibility gene for familial non-medullary thyroid cancer
• Oncological features of sporadic vs. hereditary pediatric medullary thyroid cancer
• Paraneoplastic Diarrhea From Medullary Thyroid Carcinoma Resolved With Yttrium-90 Radioembolization of Liver Metastases
• Patient-reported outcomes with selpercatinib treatment in patients with RET-driven cancers in the phase I/II LIBRETTO-001 trial
• Personalized Management of Malignant and Non-Malignant Ectopic Mediastinal Thyroid: A Proposed 10-Item Algorithm Approach
• Predicting overall survival from tumor dynamics metrics using parametric statistical and machine learning models: application to patients with <em>RET</em>-altered solid tumors
• Predictive and prognostic value of aurora kinase A combined with tumor-infiltrating lymphocytes in medullary thyroid carcinoma
• Primary resistance to selpercatinib in a patient with advanced medullary thyroid cancer
• Progastrin-Releasing Peptide As a Diagnostic Biomarker of Pulmonary and Non-Pulmonary Neuroendocrine Neoplasms
• Progress and controversy on the extent of surgery for medullary thyroid carcinoma based on calcitonin levels
• Promoting Female Surgeons Through Structured Award Nominations
• Prospective assessment of canine thyroid cancer-part I: nodal metastatic rate and impact of nodal immunohistochemistry in 70 dogs
• Pulmonary BRAF-driven Langerhans cell histiocytosis following selpercatinib use in metastatic medullary thyroid cancer
• Radiolabeled Somatostatin Analogs for Cancer Imaging
• Research progress of nonsyndromic familial non-medullary thyroid carcinoma
• RET Alterations Differentiate Molecular Profile of Medullary Thyroid Cancer
• Safety and efficacy of nintedanib as second-line therapy for patients with differentiated or medullary thyroid cancer progressing after first-line therapy. A randomized phase II study of the EORTC Endocrine Task Force (protocol 1209-EnTF)
• Severe hypereosinophilia as a paraneoplastic syndrome in a patient with differentiated thyroid cancer
• Simultaneous occurrence of papillary thyroid carcinoma, medullary thyroid carcinoma, and lymphoma: A case report
• Spontaneous and Treatment-Related Changes of Serum Calcitonin in Medullary Thyroid Cancer: Long-Term Experience in a Patient With Multiple Endocrine Neoplasia Type 2B
• The impact of preoperative calcitonin screening on the prognosis of patients with medullary thyroid cancer: a retrospective multicenter cohort study
• The Influence of N-Acetyl-selenomethionine on Two RONS-Generating Cancer Cell Lines Compared to N-Acetyl-methionine
• The machine learning-based model for lateral lymph node metastasis of thyroid medullary carcinoma improved the prediction ability of occult metastasis
• The Multi-institutional Medullary Thyroid Cancer Collaborative Registry (MTCCoRe): Can a rare tumor registry accurately represent the real-world patient population?
• The Multi-Institutional Medullary Thyroid Cancer Collaborative Registry: Can a Rare Tumor Registry Accurately Represent the Real-World Patient Population?
• The neurotransmitter calcitonin gene-related peptide shapes an immunosuppressive microenvironment in medullary thyroid cancer
• The pathological characteristics and prognostic analysis of medullary thyroid microcarcinoma
• The real-world safety profile of tirzepatide: pharmacovigilance analysis of the FDA Adverse Event Reporting System (FAERS) database
• The Role of [18F]F-DOPA PET/CT in Diagnostic and Prognostic Assessment of Medullary Thyroid Cancer: A 15-Year Experience with 109 Patients
• The WHO 2022 Classification of Renal Neoplasms (5th Edition): Salient Updates
• Thyroid carcinomas: the role of systemic therapies in internal medicine
• Thyroid surgery in children: a single-center experience of 20 years
• Time Kinetics and prognosis roles of calcitonin after surgery for medullary thyroid carcinoma
• Timing and Ideal Patient for an Appropriate Search for Somatic RET Mutation in Medullary Thyroid Cancer
• Transcriptomic Differences in Medullary Thyroid Carcinoma According to Grade
• Tumor deposits in thyroid carcinomas
• Tumor desmoplasia outperforms preoperative serum calcitonin as surgical biomarker in sporadic medullary thyroid cancer
• Well-defined survival outcome disparity across age cutoffs at 45 and 60 for medullary thyroid carcinoma: a long-term retrospective cohort study of 3601 patients